Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Tali FDA Approval on Track for Feb'12
Go back to Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Tali FDA Approval on Track for Feb'12| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.38 +0.03 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.35 | 52 Week High | $1.11 | |||
| Open | $2.32 | 52 Week Low | $0.41 | |||
| Day High | $2.39 | P/E | N/A | |||
| Day Low | $2.31 | EPS | $-0.29 | |||
| Volume | 384,984 | |||||
